Patent · US Expired

Biologically active vasopressin analogues

US5698516A · kind A · utility

36Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 1995
Grant dateDec 16, 1997
Priority date
Expiry dateDec 18, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/15
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vasopressin analogues of formula (I) ##STR1## wherein X is (S)-2-amino-2-methyl-butanoic acid (CaMeAbu) or Valine (Val), Y is Thienylalanine (Thi) or Methionine (Met), Z is D-Phenylalanine (D-Phe) or D-Thienylalanine (Thi) or D-Tyrosine (D-Tyr), are disclosed. Pharmaceutical preparations comprising a vasopressin analogue of the invention as active ingredient are disclosed and exemplified by oral preparations, nasal preparations, and intravenous preparations. The vasopressin analogues of the invention are intended for use as a medicament, specially an antidiuretic agent. The antidiuretic agent is preferably used for the treatment of diabetes insipidus or enuresis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.